[Case Study] Koji Masuda and Kenji Ikeda “TDM Is Not Only for Safety, but for Ensuring Effectiveness” (AMR Alliance Japan, March 31, 2022)
date : 3/31/2022
Tags: AMR
As part of a project to promote antimicrobial steward among medical professionals, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has been publishing case studies from various experts related to antimicrobial resistance.
The latest case report was created by Dr. Koji Masuda (Vice Chief Pharmacist, Department of Pharmacy, International Healthcare and welfare University, NARITA Hospital) and Dr. Kenji Ikeda (Chief Pharmacist, International Healthcare and welfare University, NARITA Hospital / Deputy Director, Department of Pharmacy, Narita Hospital, International University of Health and Welfare). It is entitled, “TDM Is Not Only for Safety, but for Ensuring Effectiveness.”
This is the third of three case studies from AMR Alliance Japan on the usefulness of TDM for antimicrobial stewardship.
Case study 08
Dr. Koji Masuda (Vice Chief Pharmacist, Department of Pharmacy, International Healthcare and welfare University, NARITA Hospital)
Dr. Kenji Ikeda (Chief Pharmacist, International Healthcare and welfare University, NARITA Hospital / Deputy Director, Department of Pharmacy, Narita Hospital, International University of Health and Welfare)
“TDM Is Not Only for Safety, but for Ensuring Effectiveness.”
For further information, please see the case study below.
■ Case studies from various experts related to AMR
Case study 07 – Patient’s Voice
Ms. Sachiko Ito (Supporter, AMR Alliance Japan / Person Affected by Non-tuberculous Mycobacterial (NTM) Lung Disease)
“I hope more healthcare professionals take an interest in Antimicrobial Resistance (AMR) and work to promote the appropriate usage of antimicrobials.”
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)



